Pharmafile Logo
Pharmafocus logo
Advanced Search
rich_baptista

Rich Baptista joins Synergy Vision

September 1, 2011
Medical Communications London, Quintiles, agency, appointment, chiltern, comms, communications, creativity, digital, excellence, innovation, leader, leadership, marketing, med, medical, medical communcations, success

London-based medical communications agency Synergy Vision has appointed Rich Baptista as strategic alliance director with a brief to focus on …

Appointment
Roche's Tarceva (erlotinib)

Tarceva approval for first-line use in EGFR lung cancer

September 1, 2011
Sales and Marketing NSCLC, Roche, Tarceva

Tarceva has been granted final European approval for patients with a genetically distinct type of non-small cell lung cancer (NSCLC). …

News

Shire’s Firazyr gains US approval after initial setback

September 1, 2011
Sales and Marketing FDA, Firazyr, Shire

After three years of waiting Shire’s Firazyr has been approved by the FDA for sudden attacks of swelling. The US …

News

Merck acquires cell imaging instrument maker Amnis

September 1, 2011
Research and Development Merck KGaA, Millipore

EMD Millipore, the Massachussetts-based life sciences arm of Merck KGaA, has bought US cell imaging instrument maker Amnis Corporation for …

News

Boehringer expands afatinib breast cancer trials

August 31, 2011
Research and Development Boehringer, afatinib

Boehringer Ingelheim has begun two new phase II trials of its investigational cancer drug afatinib. The studies will cover afatinib’s …

News

FDA wants more information on Novartis arthritis drug

August 31, 2011
Sales and Marketing FDA, Ilaris, Novarits, canakinumab

The FDA has asked Novartis for more information on its gouty arthritis drug canakinumab. The regulator’s request came in a …

News
Boehringer Ingelheim

Pradaxa and Eliquis gain trial boost over warfarin

August 31, 2011
Sales and Marketing Eliquis, Pradaxa, Xarelto, apixaban

A pair of new blood thinners are superior to warfarin when it comes to reducing the risk of stroke in …

News

Nurofen Plus recall expanded

August 31, 2011
Sales and Marketing MHRA, Nurofen, recalls

Last week’s recall of Reckitt Benckiser’s painkiller product Nurofen Plus has been expanded after two additional cases emerged where powerful …

News

FDA approves Pfizer’s lung cancer drug Xalkori

August 30, 2011
Sales and Marketing FDA, Pfizer, Xalkori, crizotinib

Pfizer’s lung cancer drug Xalkori has been approved by the FDA, a month ahead of schedule. Xalkori (crizotinib) is now …

News

Teva in the dock again for hepatitis link to propofol

August 30, 2011
Manufacturing and Production Teva, manufacturing and production news, propofol

Teva’s decision to shut down a manufacturing facility for the anaesthetic propofol has become a focal point in a US …

News

GE gets bigger in upstream bioprocessing with PAA Labs buy

August 30, 2011
Manufacturing and Production GE Healthcare, PAA Labs, manufacturing and production news

General Electric unit GE Healthcare has continued to expand its life sciences business with an agreement to buy privately-held PAA …

News

Catalent to buy Aptuit and claim number two spot in clinical supply

August 30, 2011
Manufacturing and Production Aptuit, Catalent, manufacturing and production news

Catalent Pharma Solutions has agreed to purchase the clinical trial supply business of Aptuit in a $410 million deal which …

News

New electronic submission validation criteria

August 29, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

On Thursday 1st September a new version of the validation criteria for electronic submissions for human medicines will come into …

News
Press release

MSD sways NICE with Simponi patient access scheme

August 26, 2011
Sales and Marketing NICE, Simponi, ankylosing spondylitis

A patient access scheme which lowers Simponi’s cost has led to Merck Sharp and Dohme’s drug being given the thumbs …

News
Boehringer - Lilly's Trajenta (linagliptin)

Boehringer-Lilly’s Trajenta wins European approval

August 26, 2011
Sales and Marketing Tradjenta, Trajenta, diabetes

Boehringer Ingelheim and Eli Lilly’s new type II diabetes drug Trajenta has been approved Europe. The European Commission backed Trajenta …

News

Reckitt painkiller packs may contain antipsychotics, says MHRA

August 26, 2011
Manufacturing and Production, Sales and Marketing MHRA, Nurofen, Seroquel, parallel imports

Consumers in the UK are being warned to double-check packs of Reckitt Benckiser’s painkiller product Nurofen Plus following reports that …

News
rock_medical_communications_ash_rishi

Rock adds four new starters

August 26, 2011
Medical Communications appointments, medical communications

Rock Medical Communications has appointed four new people to its specialist medical education team. Sam Flynn joins as account manager …

Appointment

Google fined $500m for online drug advertising

August 26, 2011
Medical Communications, Sales and Marketing Google Adwords, counterfeits, google

Google has been fined $500 million by the US government for allowing pharmacies based in Canada to advertise unlicenced drugs …

News

AkzoNobel appoints new investor relations director

August 25, 2011
Sales and Marketing appointment, sales and marketing

Jonathan Atack is set to join AkzoNobel as the company’s new corporate director of investor relations. He was most recently …

Appointment

Market access and the new NHS in England

August 25, 2011
Sales and Marketing NHS, NHS reforms

The National Health Service in England is undergoing massive structural and financial upheaval, and pharma marketers will be rightly concerned …

Feature
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026